Market

Cash Flow

You can view the Balance Sheet for the last 5 years.

BALANCE SHEET

Symbiotec Pharmalab Ltd.

GO
Market Cap. ( ₹ in Cr. ) 7021.91 P/BV 6.11 Book Value ( ₹ ) 178.98
52 Week High/Low ( ₹ ) 1180/934 FV/ML 2/1 P/E(X) 63.90
Book Closure EPS ( ₹ ) 17.10 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 12Mar 11Mar 10
Months121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARAR
FaceValue2.002.002.00
No. of Equity Shares (in Lacs)627.35546.82546.82
    
EQUITIES AND LIABILITIES   
SHAREHOLDER'S FUNDS   
Equity Share Capital12.5510.9410.94
Total Share Capital12.5510.9410.94
    
Reserves and Surplus1137.18803.96704.11
Total Reserves and Surplus1137.18803.96704.11
Total Shareholders Funds1149.73814.89715.05
Minority Interest-0.14-0.19-0.21
    
NON-CURRENT LIABILITIES   
Long Term Borrowings68.41253.01195.24
Deferred Tax Liabilities [Net]5.8121.9919.94
Other Long Term Liabilities7.844.092.84
Long Term Provisions21.5713.2510.70
Total Non-Current Liabilities103.64292.35228.73
    
CURRENT LIABILITIES   
Short Term Borrowings319.50287.9151.96
Trade Payables138.3388.50227.61
Other Current Liabilities63.1592.0768.00
Short Term Provisions6.594.133.64
Total Current Liabilities527.57472.60351.21
    
Total Capital And Liabilities1780.791579.651294.79
    
ASSETS   
NON-CURRENT ASSETS   
Tangible Assets1120.33438.00448.19
Intangible Assets0.000.000.24
Capital Work-In-Progress64.48568.17208.32
Fixed Assets1184.811006.17656.74
Non-Current Investments4.481.453.51
Other Non-Current Assets105.9679.18126.32
Total Non-Current Assets1295.251086.79786.58
    
    
CURRENT ASSETS   
Inventories236.88261.45335.79
Trade Receivables197.60175.65125.67
Cash And Cash Equivalents10.1326.477.56
OtherCurrentAssets40.9429.2839.19
Total Current Assets485.54492.86508.21
    
Total Assets1780.791579.651294.79
    
OTHER INFORMATION   
    
CONTINGENT LIABILITIES, COMMITMENTS   
Contingent Liabilities100.3737.22122.70
    
NON-CURRENT INVESTMENTS   
Non-Current Investments Unquoted Book Value4.481.453.51
ParticularsMar 12
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue2.00
No. of Equity Shares (in Lacs)627.35
  
EQUITIES AND LIABILITIES 
SHAREHOLDER'S FUNDS 
Equity Share Capital12.55
Total Share Capital12.55
Reserves and Surplus1137.18
Total Reserves and Surplus1137.18
Total Shareholders Funds1149.73
Minority Interest-0.14
NON-CURRENT LIABILITIES 
Long Term Borrowings68.41
Deferred Tax Liabilities [Net]5.81
Other Long Term Liabilities7.84
Long Term Provisions21.57
Total Non-Current Liabilities103.64
CURRENT LIABILITIES 
Short Term Borrowings319.50
Trade Payables138.33
Other Current Liabilities63.15
Short Term Provisions6.59
Total Current Liabilities527.57
Total Capital And Liabilities1780.79
ASSETS 
NON-CURRENT ASSETS 
Tangible Assets1120.33
Intangible Assets0.00
Capital Work-In-Progress64.48
Fixed Assets1184.81
Non-Current Investments4.48
Other Non-Current Assets105.96
Total Non-Current Assets1295.25
CURRENT ASSETS 
Inventories236.88
Trade Receivables197.60
Cash And Cash Equivalents10.13
OtherCurrentAssets40.94
Total Current Assets485.54
Total Assets1780.79
OTHER INFORMATION 
CONTINGENT LIABILITIES, COMMITMENTS 
Contingent Liabilities100.37
NON-CURRENT INVESTMENTS 
Non-Current Investments Unquoted Book Value4.48
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.